Skip to content

Clinical trials

Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Country / region: Netherlands Clear all

452 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20035
20046
200510
200611
200713
200822
200917
201016
201117
201218
201319
201425
201522
201616
201731
201824
201936
202017
202119
202224
202322
202426
202518
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed248
Recruiting74
Terminated50
Active, not recruiting43
Unknown status30
Not yet recruiting4
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center24
GlaxoSmithKline22
Novartis Pharmaceuticals22
AstraZeneca19
University Medical Center Groningen18
AbbVie15
Hoffmann-La Roche15
Amgen14
Erasmus Medical Center13
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms452
Carcinoma, Non-Small-Cell Lung38
Neoplasm Metastasis36
Breast Neoplasms26
Colorectal Neoplasms26
Lung Neoplasms26
Neoplasms by Site23
Carcinoma20
Recurrence18
Prostatic Neoplasms17

Trials

Showing 76 to 100 of 452. Each trial links to its page on Pharma Observatory.

352 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.